Rheumatoid arthritis (RA) is a very painful, chronic inflammatory, disease predominantly afflicting the joints. Biotest develops innovative therapeutic strategies with the objective of improving quality of life for RA patients, which is usually severely limited. The focus is on the monoclonal antibody BT-061.